In our published reports, marked decline in arylsulfatase B (ARSB; N-acetylgalactosamine-4-sulfatase) was associated with earlier biochemical recurrences and with higher Gleason scores in prostate cancers [28, 29]. The gene discussed is ARSB; the disease is prostate carcinoma.